Trump administration signs up new company to make Covid-19 drugs in US

  • 📰 IOL
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

ประเทศไทย ข่าว ข่าว

Donald Trump's administration awarded a contract worth up to $812 million for a new US company to manufacture drugs and ingredients to fight Covid-19 on American soil, aiming to end dependence on other countries.

US President Donald Trump's administration awarded a contract worth up to $812 million for a new US company to manufacture drugs and drug ingredients to fight Covid-19 on American soil, aiming to end dependence on other countries.

Navarro for months has been advocating that Trump issue an executive order to require federal agencies to buy US-made medical supplies and pharmaceuticals. The company is run by Eric Edwards, who previously founded the drug company Kaleo Pharmaceuticals with his twin brother. He said in an interview that Phlow initially reached out to the U.S. health department last November, to tell them that they were working to build US drug manufacturing capacity.

The company submitted a proposal on drug manufacturing in response to an open request from the Biomedical Advanced Research and Development Authority, one of the HHS agencies overseeing Covid-19 vaccine and drug development, he said.

 

ขอบคุณสำหรับความคิดเห็นของคุณ ความคิดเห็นของคุณจะถูกเผยแพร่หลังจากได้รับการตรวจสอบแล้ว

State capture? Is that you?

Legend

เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:

 /  🏆 46. in TH

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว